Masato Nagaoka Selected Research

YHO-13351

4/2013

ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masato Nagaoka Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 05/2011
2	Emergence Delirium 01/2018 - 01/2017
2	Esophageal Neoplasms (Esophageal Cancer) 03/2017 - 01/2016
2	Experimental Sarcoma 01/2015 - 06/2010
2	Infections 11/2008 - 02/2003
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Experimental Melanoma 11/2020
1	Hypopharyngeal Neoplasms 03/2017
1	Necrosis 01/2016
1	Anastomotic Leak 01/2016
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2016
1	Adenoid Cystic Carcinoma (Cylindroma) 12/2015
1	Glucose Intolerance 02/2014
1	Type 2 Diabetes Mellitus (MODY) 02/2014
1	Breast Neoplasms (Breast Cancer) 04/2013
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2012
1	Colorectal Neoplasms (Colorectal Cancer) 05/2011
1	Teratoma (Teratoid Tumor) 06/2010
1	Drug-Related Side Effects and Adverse Reactions 01/2010
1	Metabolic Diseases (Metabolic Disease) 01/2010
1	Virus Diseases (Viral Diseases) 11/2008
1	Gastritis 02/2003

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 01/2010
2	ramelteon (Rozerem)FDA Link 01/2018 - 01/2017
2	suvorexantIBA 01/2018 - 01/2017
2	matrigelIBA 01/2015 - 06/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 06/2010
2	fucoidanIBA 11/2008 - 02/2003
1	geldanamycinIBA 01/2021
1	AnnexinsIBA 01/2021
1	Annexin A1IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	chlorotriphenylsilane (CTPS)IBA 01/2021
1	LuciferasesIBA 11/2020
1	Proteoglycans (Proteoglycan)IBA 01/2015
1	Complex MixturesIBA 01/2015
1	Extracellular Matrix ProteinsIBA 01/2015
1	PhytochemicalsIBA 02/2014
1	EquolIBA 02/2014
1	Blood Glucose (Blood Sugar)IBA 02/2014
1	daidzeinIBA 02/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2014
1	YHO-13351IBA 04/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	LipidsIBA 12/2012
1	oxidized low density lipoproteinIBA 12/2012
1	CholesterolIBA 12/2012
1	LDL Receptors (LDL Receptor)IBA 12/2012
1	LDL CholesterolIBA 12/2012
1	EnzymesIBA 05/2011
1	Colchicine FDA LinkGeneric 05/2011
1	ProdrugsIBA 05/2011
1	Cathepsin BIBA 05/2011
1	DipeptidesIBA 05/2011
1	Glucuronic Acid (Glucuronate)IBA 11/2008
1	Glucose (Dextrose)FDA LinkGeneric 11/2008
1	Gastric MucinsIBA 02/2003

Therapy/Procedure

4	Esophagectomy 01/2018 - 01/2016
1	Intravenous Injections 01/2021
1	Chemoradiotherapy 03/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Proton Therapy 12/2015
1	Drug Therapy (Chemotherapy) 04/2013